Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Genotype 1B”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Early research (Phase 1)Study completedNCT00630058
What this trial is testing

MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis C

Who this might be right for
Hepatitis C
Tanabe Pharma Corporation 20
Large-scale testing (Phase 3)Study completedNCT03186365
What this trial is testing

8 Weeks Versus 12 Weeks of Elbasvir/Grazoprevir in Treatment-naïve CHC With Mild Fibrosis

Who this might be right for
Hepatitis C, Chronic
Kaohsiung Medical University Chung-Ho Memorial Hospital 82
Post-approval studies (Phase 4)Study completedNCT00245414
What this trial is testing

Trial of Pegasys® in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Chugai Pharmaceutical 108
Testing effectiveness (Phase 2)Study completedNCT01672983
What this trial is testing

Evaluate ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Japanese Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie (prior sponsor, Abbott) 110
Large-scale testing (Phase 3)Study completedNCT02216422
What this trial is testing

Evaluate Chronic Hepatitis C Virus (HCV) Infection in Cirrhotic Adults With Genotype 1b (GT1b) Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection
AbbVie 36
Not applicableStudy completedNCT01342003
What this trial is testing

HCV Genotype 1a Shows a Better Virological Response to Antiviral Therapy Than HCV Genotype 1b

Who this might be right for
Chronic Hepatitis C
Azienda Ospedaliera San Camillo Forlanini 388
Early research (Phase 1)Ended earlyNCT01425190
What this trial is testing

Pharmacokinetics of Boceprevir in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P07614)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 16
Post-approval studies (Phase 4)Ended earlyNCT03723824
What this trial is testing

Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney Transplantation

Who this might be right for
Chronic Hepatitis cLiver Transplant InfectionKidney Transplant Infection
Taichung Veterans General Hospital 14
Testing effectiveness (Phase 2)Study completedNCT00621296
What this trial is testing

Safety and Efficacy of MP-424 to Treat Chronic Hepatitis C

Who this might be right for
Hepatitis C
Tanabe Pharma Corporation 15
Early research (Phase 1)Study completedNCT00591214
What this trial is testing

Safety and PK Study of MP-424 to Treat Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Tanabe Pharma Corporation 10
Not applicableStudy completedNCT03053180
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian Federation

Who this might be right for
Chronic Hepatitis C
AbbVie 60
Large-scale testing (Phase 3)Study completedNCT01581203
What this trial is testing

Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives)

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 748
Large-scale testing (Phase 3)Study completedNCT02219503
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis

Who this might be right for
Chronic Hepatitis C InfectionCompensated Cirrhosis
AbbVie 60
Testing effectiveness (Phase 2)Study completedNCT02583685
What this trial is testing

Switching Regimen in Treating Cirrhotic HCV GT1b Subjects

Who this might be right for
Chronic Hepatitis C Infection
Humanity and Health Research Centre 138
Testing effectiveness (Phase 2)Study completedNCT02340962
What this trial is testing

Evaluate the Efficacy and Safety of TG-2349 in Subjects With Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
TaiGen Biotechnology Co., Ltd. 25
Testing effectiveness (Phase 2)Study completedNCT00695019
What this trial is testing

Interferon-alpha Lozenges for Prevention of Relapse in Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. 169
Post-approval studies (Phase 4)Study completedNCT03050905
What this trial is testing

Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1B

Who this might be right for
HCV Coinfection
HaEmek Medical Center, Israel 7
Testing effectiveness (Phase 2)Study completedNCT01724086
What this trial is testing

Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Patients Infected With Chronic Genotype 1 Hepatitis C Virus

Who this might be right for
Chronic Hepatitis C
Janssen R&D Ireland 90
Early research (Phase 1)Study completedNCT00372983
What this trial is testing

Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard Therapy

Who this might be right for
Hepatitis C
Cellectar Biosciences, Inc. 30
Not applicableUnknownNCT02865369
What this trial is testing

Regression of Liver Fibrosis After Daclatasvir and Asunaprevir Treatment

Who this might be right for
Chronic Hepatitis C
Sang Gyune Kim 103
Next Page